These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 2002092)

  • 1. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis.
    Maimone D; Gregory S; Arnason BG; Reder AT
    J Neuroimmunol; 1991 Apr; 32(1):67-74. PubMed ID: 2002092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis.
    Tsukada N; Miyagi K; Matsuda M; Yanagisawa N; Yone K
    J Neurol Sci; 1991 Aug; 104(2):230-4. PubMed ID: 1940977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approach to discriminate subgroups in multiple sclerosis with cerebrospinal fluid (CSF) basic inflammation indices and TNF-alpha, IL-1beta, IL-6, IL-8.
    Kleine TO; Zwerenz P; Graser C; Zöfel P
    Brain Res Bull; 2003 Aug; 61(3):327-46. PubMed ID: 12909303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-12 and tumor necrosis factor-alpha levels in cerebrospinal fluid of multiple sclerosis patients.
    Drulović J; Mostarica-Stojković M; Lević Z; Stojsavljević N; Pravica V; Mesaros S
    J Neurol Sci; 1997 Apr; 147(2):145-50. PubMed ID: 9106119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
    Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
    J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients.
    Wen SR; Liu GJ; Feng RN; Gong FC; Zhong H; Duan SR; Bi S
    J Neuroimmunol; 2012 Mar; 244(1-2):94-6. PubMed ID: 22329905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th1/Th2 cytokine balance and nitric oxide in cerebrospinal fluid and serum from patients with multiple sclerosis.
    Rodríguez-Sáinz Mdel C; Sánchez-Ramón S; de Andrés C; Rodríguez-Mahou M; Muñoz-Fernández MA
    Eur Cytokine Netw; 2002; 13(1):110-4. PubMed ID: 11956029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6.
    Hauser SL; Doolittle TH; Lincoln R; Brown RH; Dinarello CA
    Neurology; 1990 Nov; 40(11):1735-9. PubMed ID: 2234430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases.
    Michalopoulou M; Nikolaou C; Tavernarakis A; Alexandri NM; Rentzos M; Chatzipanagiotou S; Cambouri C; Vassilopoulos D
    Immunol Lett; 2004 Jul; 94(3):183-9. PubMed ID: 15275965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid and serum protein levels of tumour necrosis factor-alpha (TNF-alpha) interleukin-6 (IL-6) and soluble interleukin-6 receptor (sIL-6R gp80) in multiple sclerosis patients.
    Vladić A; Horvat G; Vukadin S; Sucić Z; Simaga S
    Cytokine; 2002 Oct; 20(2):86-9. PubMed ID: 12445803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute?
    Bayart JL; Muls N; van Pesch V
    Acta Neurol Scand; 2018 Oct; 138(4):352-358. PubMed ID: 29900542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of interleukin-1beta and soluble intercellular adhesion molecule-1 in cerebrospinal fluid of patients with subacute sclerosing panencephalitis.
    Mehta PD; Kulczycki J; Mehta SP; Coyle PK; Wisniewski HM
    J Infect Dis; 1997 Mar; 175(3):689-92. PubMed ID: 9041345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study.
    Olesen MN; Soelberg K; Debrabant B; Nilsson AC; Lillevang ST; Grauslund J; Brandslund I; Madsen JS; Paul F; Smith TJ; Jarius S; Asgari N
    J Neuroinflammation; 2019 Mar; 16(1):59. PubMed ID: 30857557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment.
    Ozenci V; Kouwenhoven M; Huang YM; Kivisäkk P; Link H
    Clin Exp Immunol; 2000 Apr; 120(1):147-53. PubMed ID: 10759776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
    Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
    Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and CSF levels of IL-2, sIL-2R, TNF-alpha, and IL-1 beta in chronic progressive multiple sclerosis: expected lack of clinical utility.
    Peter JB; Boctor FN; Tourtellotte WW
    Neurology; 1991 Jan; 41(1):121-3. PubMed ID: 1985276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Maimone D; Annunziata P; Simone IL; Livrea P; Guazzi GC
    J Neuroimmunol; 1993 Aug; 47(1):55-61. PubMed ID: 8376548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter Hyperintensities.
    Levraut M; Landes C; Mondot L; Cohen M; Bresch S; Brglez V; Seitz-Polski B; Lebrun-Frenay C
    Front Immunol; 2022; 13():864133. PubMed ID: 35401550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma delta T cell distribution in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis.
    Droogan AG; Crockard AD; Hawkins SA; McNeill TA
    J Neurol Sci; 1994 Nov; 126(2):172-7. PubMed ID: 7853024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.